Publications by authors named "F Isbaniah"
Objectives: Countries in the South East Asian region face similar challenges in control of infectious diseases. There is limited access to experiences and learnings of neighboring countries. The Indian Council - of Medical Research (ICMR) has established a Regional Enabler for the South-East Asia Research Collaboration for Health (RESEARCH) Platform for South East Asian Region (SEAR) countries to address the above issues.
View Article and Find Full Text PDFThis study aimed to determine the real-world safety and effectiveness of remdesivir in hospitalized adult COVID-19 patients with moderate-to-critical disease in Indonesia. A multicenter, retrospective cohort study was conducted at four COVID-19 referral hospitals in Jakarta. A total of 587 patients were included, of whom 243 received remdesivir within 72 h of admission.
View Article and Find Full Text PDFArticle Synopsis
- * 93 healthcare providers studied showed a significant increase in SARS-CoV-2 antibody levels three months post-booster, rising from a median of 1.7 U/mL to 9540 U/mL.
- * Findings suggest that the heterologous Moderna booster not only boosts antibody response but also results in mostly mild COVID-19 symptoms among those who contract the virus afterwards.
Article Synopsis
- A study on the long-term effects of COVID-19 in Indonesia found that 66.5% of survivors reported persistent symptoms, notably fatigue, cough, and muscle pain.
- The research was conducted through an online questionnaire among adult Indonesians who had recovered from the virus, with a focus on the correlation between health conditions and quality of life.
- Results indicated pneumonia as the most significant factor linked to persistent COVID-19 syndrome, highlighting the need for additional research to better understand and mitigate its impacts on health and well-being.
Determinants of treatment outcomes in patients with multidrug-resistant TB.
Int J Tuberc Lung Dis
February 2022
Article Synopsis
- Treating multidrug-resistant tuberculosis (MDR-TB) is challenging, and understanding the reasons for poor treatment outcomes is still limited.
- A study in Jakarta analyzed adult MDR-TB patients from 2013 to 2016, looking at factors like age, diabetes, and HIV co-infection that impact treatment success.
- Key findings showed that older age and specific health issues significantly increase the risk of death or loss to follow-up, with different risks appearing at different times during treatment.